Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07100626 · ClinicalTrials.gov registry record · NA

In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization

A NA study of Dental Caries, sponsored by Incisive Technologies Pty.

Active
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT07100626 is a NA study of Dental Caries that is active but no longer recruiting, run by Incisive Technologies Pty. The registered enrollment target is 12 participants, below the 722-participant average among 30 other Dental Caries trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07100626, a NA study of Dental Caries, is active but no longer recruiting, sponsored by Incisive Technologies Pty.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to evaluate whether BlueCheck® can accurately detect and monitor early-stage dental caries (tooth decay) and their remineralization in adults. Participants will wear partial dentures with partially demineralized human enamel specimens. The main questions it aims to answer are: * Can BlueCheck® reliably detect early carious lesions with high sensitivity and specificity? * Does BlueCheck® visually reflect changes in remineralized enamel lesions? BlueCheck® results will be compared against standard diagnostic methods (e.g., Nyvad criteria, Diagnodent readings, surface microhardness) to see if BlueCheck® provides an objective, accurate, and visual method of detecting and monitoring early-stage caries. Participants will: * Wear a modified lower partial denture with four mounted enamel specimens for 28 days. * Use only the study-provided fluoride containing toothpaste * Attend weekly clinic visits for removal and laboratory analysis of one enamel specimen per week. * Undergo regular oral health checks and provide diary entries tracking brushing and any adverse events.

Conditions Studied

Interventions

  • DEVICE BlueCheck

Study Locations (1)

Indiana

  • Oral Health Research Institute - Indianapolis

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2025-09-24
Est. Completion 2026-01
Phase NA

Sponsor

Incisive Technologies Pty

1 total trials

What the Registry Record Tells You About NCT07100626

The ClinicalTrials.gov registry entry for NCT07100626 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 722-participant average among 30 other Dental Caries trials with a reported enrollment target (98% lower). The listed sponsor is Incisive Technologies Pty, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Dental Caries appearing as the primary indexed condition, and to 1 intervention - of which BlueCheck is the first listed.

NCT07100626 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT07100626 about?

NCT07100626 is a clinical study titled "In-situ Clinical Trial Assessing Ability to Detect and Monitor Active Caries and Their Remineralization". The goal of this clinical trial is to evaluate whether BlueCheck® can accurately detect and monitor early-stage dental caries (tooth decay) and their remineralization in adults. Participants will wear partial dentures with partially demineralized human enamel specimens. The main questions it aims to...

What is the current status of trial NCT07100626?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2025-09-24. Estimated completion is 2026-01.

What conditions does trial NCT07100626 study?

This clinical trial studies the following conditions: Dental Caries.

What interventions are being tested in trial NCT07100626?

The interventions under investigation include: BlueCheck (DEVICE).

Who is sponsoring clinical trial NCT07100626?

This trial is sponsored by Incisive Technologies Pty, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07100626 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dental Caries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.